Systemic Treatment of Acute Liver Failure with Adipose Derived Stem Cells

REFERENCES

• Burra P, Arcidiacono D, Bizzaro D, Chioato T, et al. Systemic administration of a novel human umbilical cord mesenchymal stem cells population accelerates the resolution of acute liver injury. BMC Gastroenterol. 2012;12:88.
   PubMed Web of Science ®Google Scholar
• Banas A, Teratani T, Yamamoto Y, et al. Rapid hepatic fate specification of adipose-derived stem cells and their therapeutic potential for liver failure. J Gastroenterol Hepatol. 2009;24:70–77.
   PubMed Web of Science ®Google Scholar
• Viswanathan P, Gupta S. New directions for cell-based therapies in acute liver failure. J Hepatol. 2012;57:913–915.
   Google Scholar
• Loukopoulos I, Sfiniadakis I, Pillai A, et al. Mycophenolate mofetil and sirolimus in hepatocyte transplantation in an experimental model of toxic acute liver failure. J Invest Surg. 2014;27:205–213.
   PubMed Web of Science ®Google Scholar
• Herrera MB, Fonsato V, Bruno S, et al. Human liver stem cells improve liver injury in a model of fulminant liver failure. Hepatology 2013;57:311–319.
   PubMed Web of Science ®Google Scholar
• Pietrosi G, Vizzini GB, Gruttadauria S, et l. Clinical applications of hepatocyte transplantation. World J Gastroenterol. 2009;15:2074–2077.
   PubMed Web of Science ®Google Scholar
• Palmes D, Qayumi AK, Spiegel HU. Liver bridging techniques in the treatment of acute liver failure. J Invest Surg. 2000;13:299–311.
   PubMedGoogle Scholar
• Piryaei A, Valojerdi MR, Shahsavani M, et al. Differentiation of bone marrow-derived mesenchymal stem cells into hepatocyte-like cells on nanofibers and their transplantation into a carbon tetrachloride-induced liver fibrosis model. Stem Cell Rev. 2011;7:103–118.
   Web of Science ®Google Scholar
• Gruttadauria S, Grosso G, Pagano D, et al. Marrow-derived mesenchymal stem cells restore biochemical markers of acute liver injury in experimental model. Transplant Proc. 2013;45:480–486.
   PubMed Web of Science ®Google Scholar
• Liu ZC, Chang TM. Intrasplenic transplantation of bioencapsulated mesenchymal stem cells improves the recovery rates of 90% partial hepatectomized rats. Stem Cells Int. 2012. doi: 10.1155/2012/697094.
   Google Scholar
• Alemán CL, Más RM, Rodeiro I, et al. Reference database of the main physiological parameters in Sprague-Dawley rats from 6 to 32 months. Lab Anim. 1998;32:457–466.
   PubMed Web of Science ®Google Scholar
• Wahi PN, Tandon HD, Bharadwaj TP. Acute carbon tetrachloride hepatic inury; composite histological, histochemical and biochemical study. I. Histological and histochemical studies. Acta Pathol Microbiol Scand. 1955;37:305–314.
   PubMedGoogle Scholar
• Yun JW, Kim CW, Bae IH, et al. Determination of the key innate genes related to individual variation in carbon tetrachloride-induced hepatotoxicity using a pre-biopsy procedure. Toxicol Appl Pharmacol. 2009;239:55–63.
   PubMed Web of Science ®Google Scholar
• Garcia-Olmo D, Garcia-Arranz M, Herreros MD, et al. A phase I clinical trial of the treatment of Crohn's fistula by adipose mesenchymal stem cell transplantation. Dis Colon Rectum. 2005;48:1416–1423.
   PubMed Web of Science ®Google Scholar
• Pascual I, de Miguel GF, Gómez-Pinedo UA, et al. Adipose-derived mesenchymal stem cells in biosutures do not improve healing of experimental colonic anastomoses. Br J Surg. 2008;95:1180–1184.
   PubMed Web of Science ®Google Scholar
• Pascual I, Fernández de Miguel G, García Arranz M, et al. Biosutures improve healing of experimental weak colonic anastomoses. Int J Colorectal Dis. 2010;25:1447–1451.
   PubMed Web of Science ®Google Scholar
• Pareja E, Cortés M, Martínez A, et al. Hepatic cell transplantation: a new therapy in liver diseases. Cir Esp. 2010;88:3–11.
   Google Scholar
• Pareja E, Martínez A, Cortés M, et al. Hepatic cell transplantation. Technical and methodological aspects. Cir Esp. 2010;87:139–147.
   Google Scholar
• Banas A, Teratani T, Yamamoto Y, et al. IFATS collection: in vivo therapeutic potential of human adipose tissue mesenchymal stem cells after transplantation into mice with liver injury. Stem Cells. 2008;26:2705–2712.
   PubMed Web of Science ®Google Scholar
• Kim SJ, Park KC, Lee JU, et al. Therapeutic potential of adipose tissue-derived stem cells for liver failure according to the transplantation routes. J Korean Surg Soc. 2011;81(3):176–186.
   PubMed Web of Science ®Google Scholar
• Mark AL, Sun Z, Warren DS, et al. Stem cell mobilization is life saving in an animal model of acute liver failure. Ann Surg. 2010;252(4):591–596.
   Google Scholar
• Duncan AW, Dorrell C, Grompe M. Stem cells and liver regeneration. Gastroenterology. 2009;137(2):466–481.
   PubMed Web of Science ®Google Scholar
• Terblanche J, Hickman R. Animal models of fulminant hepatic failure. Dig Dis Sci. 1991;36:770–774.
   PubMedGoogle Scholar
• Weil BR, Manukyan MC, Herrmann JL, et al. The immunomodulatory properties of mesenchymal stem cells: implications for surgical disease. J Surg Res. 2011;167(1): 78–86.
   Google Scholar
• Yi T, Song SU. Immunomodulatory properties of mesenchymal stem cells and their therapeutic applications. Arch Pharm Res. 2012;35(2):213–221.
   PubMed Web of Science ®Google Scholar
• Georgiev-Hristov T, García-Arranz M, García-Gómez I, et al. Sutures enriched with adipose-derived stem cells decrease the local acute inflammation after tracheal anastomosis in a murine model. Eur J Cardiothorac Surg. 2012;42(3):40–47.
   Google Scholar
• Trebol Lopez J, Georgiev Hristov T, et al. Stem cell therapy for digestive tract diseases: current state and future perspectives. Stem Cells Dev. 2011;20:1113–1129.
   Google Scholar
• Gonzalez Rey E, Anderson P, Gonzalez MA, et al. Human adult ítem cells derived from adipose tissue Project against experimental colitis and sepsis. Gut. 2209;58:929–939.
   Google Scholar
• Noort WA, Kruisselbrink AB, in't Anker PS, et al. Mesenchymal stem cells promote engraftment of human umbilical cord blood-derived CD34(+) cells in NOD/SCID mice. Exp Hematol. 2002;30(8):870–878.
   PubMed Web of Science ®Google Scholar